Sialyltransferases functions in cancers

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 1, 2012, Pages 499-515

  Harduin Lepers, Anne ^a,b   Krzewinski Recchi, Marie Ange ^a,b   Colomb, Florent ^a,b   Foulquier, Francois ^a,b   Groux Degroote, Sophie ^a,b   Delannoy, Philippe ^a,b  

^a UNIV LILLE   (France)

^b UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

Author keywords

Cancer; Golgi; Sialylation Review; Sialyltransferase

Indexed keywords

ALPHA 2,8 SIALYLTRANSFERASE; ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA GALACTOSIDE ALPHA 2,3 SIALYLTRANSFERASE; BETA GALACTOSIDE ALPHA 2,6 SIALYLTRANSFERASE; COMPLEMENTARY DNA; LECTIN; MESSENGER RNA; N ACETYLGALACTOSAMINE ALPHA 2,6 SIALYLTRANSFERASE; RECOMBINANT PROTEIN; SIALIC ACID; SIALYLTRANSFERASE; TUMOR ANTIGEN; UNCLASSIFIED DRUG; N ACETYLNEURAMINIC ACID;

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL PH; COLORECTAL CANCER; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME MODIFICATION; ENZYME REGULATION; ENZYME SYNTHESIS; EPIGENETICS; GENETIC LINKAGE; GOLGI COMPLEX; HISTOCHEMISTRY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; MOLECULAR CLONING; NEOPLASM; NONHUMAN; PROTEIN MICROARRAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIALYLATION; TRANSCRIPTION REGULATION; CARBOHYDRATE ANALYSIS; CHEMISTRY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; REVIEW;

CARBOHYDRATE SEQUENCE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MOLECULAR SEQUENCE DATA; N-ACETYLNEURAMINIC ACID; NEOPLASMS; SIALYLTRANSFERASES;

EID: 84860879858     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e396     Document Type: Article

References (189)

1. T. Angata & A. Varki: Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective. Chem Rev, 102, 439-469 (2002)
2. R Schauer & JP Kamerling: Chemistry,biochemistry and biology of sialic acids. In: Glycoproteins II. Eds: J Montreuil, JFG Vliegenthart&H Schachter. Elsevier, Amsterdam (1997)
3. S. Kelm & R. Schauer: Sialic acids in molecular and cellular interactions. Int Rev Cytol, 175, 137-240 (1997)
4. A. Varki: Sialic acids as ligands in recognition phenomena. Faseb J, 11, 248-255 (1997)
5. N. M. Varki & A. Varki: Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab Invest, 87, 851-857 (2007)
6. R. Schauer: Sialic acids as regulators of molecular and cellular interactions. Curr Opin Struct Biol, 19, 507-514 (2009)
7. A. Harduin-Lepers: Comprehensive Analysis of sialyltransferases in vertebrate genomes. Glycobiology Insights, 2, 29-61 (2010)
8. A. Harduin-Lepers, R. Mollicone, P. Delannoy & R. Oriol: The animal sialyltransferases and sialyltransferase-related genes: a phylogenetic approach. Glycobiology, 15, 805-817 (2005)
9. A. Harduin-Lepers, V. Vallejo-Ruiz, M. A. Krzewinski-Recchi, B. Samyn-Petit, S. Julien & P. Delannoy: The human sialyltransferase family. Biochimie, 83, 727-737 (2001)
10. F. Dall'Olio & M. Chiricolo: Sialyltransferases in cancer. Glycoconj J, 18, 841-850 (2001)
11. S. Hakomori: Aberrant glycosylation in tumors and tumorassociated carbohydrate antigens. Adv Cancer Res, 52, 257-331 (1989)
12. B. J. Campbell, I. A. Finnie, E. F. Hounsell & J. M. Rhodes: Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. J Clin Invest, 95, 571-576 (1995)
13. S. H. Itzkowitz, A. Marshall, A. Kornbluth, N. Harpaz, J. B. McHugh, D. Ahnen & D. B. Sachar: Sialosyl-Tn antigen: initial report of a new marker of malignant progression in long-standing ulcerative colitis. Gastroenterology, 109, 490-497 (1995)
14. S. Ogata, I. Ho, A. Chen, D. Dubois, J. Maklansky, A. Singhal, S. Hakomori & S. H. Itzkowitz: Tumor-associated sialylated antigens are constitutively expressed in normal human colonic mucosa. Cancer Res, 55, 1869-1874 (1995)
15. J. R. Jass, L. M. Allison & S. Edgar: Monoclonal antibody TKH2 to the cancer-associated epitope sialosyl Tn shows cross-reactivity with variants of normal colorectal goblet cell mucin. Pathology, 26, 418-422 (1994)
16. C. A. Reis, H. Osorio, L. Silva, C. Gomes & L. David: Alterations in glycosylation as biomarkers for cancer detection. J Clin Pathol, 63, 322-329 (2010)
17. S. Julien & P. Delannoy: Sialyl-Tn antigen in cancer: from diagnosis to therapy. Recent Res. Devel. Cancer, 5, 185-199 (2003)
18. H. Kitagawa & J. C. Paulson: Differential expression of five sialyltransferase genes in human tissues. J Biol Chem, 269, 17872-17878 (1994)
19. S. Groux-Degroote, A. Harduin-Lepers & P. Delannoy: Biosynthesis of mucin O-glycan chains in normal and pathological states. In: The epithelial Mucins: Structure/Function. Roles in Cancer and Inflammatory Diseases. Ed: I Van Seuningen. Research Signpost, Kerala, India (2008)
20. H. Ito, N. Hiraiwa, M. Sawada-Kasugai, S. Akamatsu, T. Tachikawa, Y. Kasai, S. Akiyama, K. Ito, H. Takagi & R. Kannagi: Altered mRNA expression of specific molecular species of fucosyl- and sialyl-transferases in human colorectal cancer tissues. Int J Cancer, 71, 556-564 (1997)
21. M. Kono, Y. Ohyama, Y. C. Lee, T. Hamamoto, N. Kojima & S. Tsuji: Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression. Glycobiology, 7, 469-479 (1997)
22. Y. C. Lee, N. Kurosawa, T. Hamamoto, T. Nakaoka & S. Tsuji: Molecular cloning and expression of Gal beta 1,3GalNAc alpha 2,3-sialyltransferase from mouse brain. Eur J Biochem, 216, 377-385 (1993)
23. V. Giordanengo, S. Bannwarth, C. Laffont, V. Van Miegem, A. Harduin-Lepers, P. Delannoy & J. C. Lefebvre: Cloning and expression of cDNA for a human Gal(beta1-3)GalNAc alpha2,3-sialyltransferase from the CEM T-cell line. Eur J Biochem, 247, 558-566 (1997)
24. N. Kojima, Y. C. Lee, T. Hamamoto, N. Kurosawa & S. Tsuji: Kinetic properties and acceptor substrate preferences of two kinds of Gal beta 1,3GalNAc alpha 2,3-sialyltransferase from mouse brain. Biochemistry, 33, 5772-5776 (1994)
25. I. Brockhausen, J. M. Yang, J. Burchell, C. Whitehouse & J. Taylor-Papadimitriou: Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur J Biochem, 233, 607-617 (1995)
26. I. Brockhausen: Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep, 7, 599-604 (2006)
27. J. Burchell, R. Poulsom, A. Hanby, C. Whitehouse, L. Cooper, H. Clausen, D. Miles & J. Taylor-Papadimitriou: An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas. Glycobiology, 9, 1307-1311 (1999)
28. G. Picco, S. Julien, I. Brockhausen, R. Beatson, A. Antonopoulos, S. Haslam, U. Mandel, A. Dell, S. Pinder, J. Taylor-Papadimitriou & J. Burchell: Over-expression of ST3Gal-I promotes mammary tumorigenesis. Glycobiology, 20, 1241-1250 (2010)
29. P. A. Videira, M. Correia, N. Malagolini, H. J. Crespo, D. Ligeiro, F. M. Calais, H. Trindade & F. Dall'Olio: ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines. BMC Cancer, 9, 357 (2009)
30. P. H. Wang, Y. F. Li, C. M. Juang, Y. R. Lee, H. T. Chao, H. T. Ng, Y. C. Tsai & C. C. Yuan: Expression of sialyltransferase family members in cervix squamous cell carcinoma correlates with lymph node metastasis. Gynecol Oncol, 86, 45-52 (2002)
31. P. H. Wang, W. L. Lee, C. M. Juang, Y. H. Yang, W. H. Lo, C. R. Lai, S. L. Hsieh & C. C. Yuan: Altered mRNA expressions of sialyltransferases in ovarian cancers. Gynecol Oncol, 99, 631-639 (2005)
32. T. Kudo, Y. Ikehara, A. Togayachi, K. Morozumi, M. Watanabe, M. Nakamura, S. Nishihara & H. Narimatsu: Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. Lab Invest, 78, 797-811 (1998)
33. M. A. Recchi, A. Harduin-Lepers, Y. Boilly-Marer, A. Verbert & P. Delannoy: Multiplex RT-PCR method for the analysis of the expression of human sialyltransferases: application to breast cancer cells. Glycoconj J, 15, 19-27 (1998)
34. M. A. Recchi, M. Hebbar, L. Hornez, A. Harduin- Lepers, J. P. Peyrat & P. Delannoy: Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res, 58, 4066-4070 (1998)
35. H. Kitagawa & J. C. Paulson: Cloning and expression of human Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase. Biochem Biophys Res Commun, 194, 375-382 (1993)
36. H. Kitagawa & J. C. Paulson: Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups. J Biol Chem, 269, 1394-1401 (1994)
37. T. Okajima, S. Fukumoto, H. Miyazaki, H. Ishida, M. Kiso, K. Furukawa, T. Urano & K. Furukawa: Molecular cloning of a novel alpha2,3- sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids. J Biol Chem, 274, 11479-11486 (1999)
38. K. Sasaki, E. Watanabe, K. Kawashima, S. Sekine, T. Dohi, M. Oshima, N. Hanai, T. Nishi & M. Hasegawa: Expression cloning of a novel Gal beta (1-3/1-4) GlcNAc alpha 2,3-sialyltransferase using lectin resistance selection. J Biol Chem, 268, 22782-22787 (1993)
39. A. S. Carvalho, A. Harduin-Lepers, A. Magalhaes, E. Machado, N. Mendes, L. T. Costa, R. Matthiesen, R. Almeida, J. Costa & C. A. Reis: Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells Int J Biochem Cell Biol, 42, 80- 89 2010
40. F. Dall'olio: Protein glycosylation in cancer biology: an overview. Clin Mol Pathol, 49, M126-135 (1996)
41. A. Cazet, S. Julien, M. Bobowski, M. A. Krzewinski-Recchi, A. Harduin-Lepers, S. Groux-Degroote & P. Delannoy: Consequences of the expression of sialylated antigens in breast cancer. Carbohydr Res (2010)
42. M. Perez-Garay, B. Arteta, L. Pages, R. de Llorens, C. de Bolos, F. Vidal-Vanaclocha & R. Peracaula: alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo. PLoS One, 5, (2010)
43. A. Ishii, M. Ohta, Y. Watanabe, K. Matsuda, K. Ishiyama, K. Sakoe, M. Nakamura, J. Inokuchi, Y. Sanai & M. Saito: Expression cloning and functional characterization of human cDNA for ganglioside GM3 synthase. J Biol Chem, 273, 31652-31655 (1998)
44. P. Berselli, S. Zava, E. Sottocornola, S. Milani, B. Berra & I. Colombo: Human GM3 synthase: a new mRNA variant encodes an NH2-terminal extended form of the protein. Biochim Biophys Acta, 1759, 348-358 (2006)
45. S. Mondal, S. Chandra & C. Mandal: Elevated mRNA level of hST6Gal I and hST3Gal V positively correlates with the high risk of pediatric acute leukemia. Leuk Res, 34, 463-470 (2010)
46. F. Dall'Olio: The sialyl-alpha2,6-lactosaminylstructure: biosynthesis and functional role. Glycoconj J, 17, 669-676 (2000)
47. D. Petit, A. M. Mir, J. M. Petit, C. Thisse, P. Delannoy, R. Oriol, B. Thisse & A. Harduin-Lepers: Molecular phylogeny and functional genomics of {beta}-galactoside {alpha}2,6-sialyltransferases that explain ubiquitous expression of st6gal1 gene in amniotes. J Biol Chem, 285, 38399-38414 (2010)
48. P. F. Rohfritsch, J. A. Joosten, M. A. Krzewinski-Recchi, A. Harduin-Lepers, B. Laporte, S. Juliant, M. Cerutti, P. Delannoy, J. F. Vliegenthart & J. P. Kamerling: Probing the substrate specificity of four different sialyltransferases using synthetic beta-D-Galp-(1→4)-beta-D- GlcpNAc-(1→2)-alpha-D-Manp-(1→O) (CH(2))7CH3 analogues general activating effect of replacing Nacetylglucosamine by N-propionylglucosamine. Biochim Biophys Acta, 1760, 685-692 (2006)
49. H. Korekane, A. Matsumoto, F. Ota, T. Hasegawa, Y. Misonou, K. Shida, Y. Miyamoto & N. Taniguchi: Involvement of ST6Gal I in the biosynthesis of a unique human colon cancer biomarker candidate, alpha2,6- sialylated blood group type 2H (ST2H) antigen. J Biochem, 148, 359-370 (2010)
50. M. A. Krzewinski-Recchi, S. Julien, S. Juliant, M. Teintenier-Lelievre, B. Samyn-Petit, M. D. Montiel, A. M. Mir, M. Cerutti, A. Harduin-Lepers & P. Delannoy: Identification and functional expression of a second human beta-galactoside alpha2,6-sialyltransferase, ST6Gal II. Eur J Biochem, 270, 950-961 (2003)
51. S. Takashima, S. Tsuji & M. Tsujimoto: Characterization of the second type of human betagalactoside alpha 2,6-sialyltransferase (ST6Gal II), which sialylates Galbeta 1,4GlcNAc structures on oligosaccharides preferentially. Genomic analysis of human sialyltransferase genes. J Biol Chem, 277, 45719-45728 (2002)
52. S. Takashima, S. Tsuji & M. Tsujimoto: Comparison of the enzymatic properties of mouse beta-galactoside alpha2,6-sialyltransferases, ST6Gal I and II. J Biochem, 134, 287-296 (2003)
53. F. Dall'Olio, N. Malagolini, G. Di Stefano, M. Ciambella & F. Serafini-Cessi: Alpha 2,6 sialylation of Nacetyllactosaminic sequences in human colorectal cancer cell lines. Relationship with non-adherent growth. Int J Cancer, 47, 291-297 (1991)
54. F. Dall'Olio, N. Malagolini & F. Serafini-Cessi: The expression of soluble and cell-bound alpha 2,6 sialyltransferase in human colonic carcinoma CaCo-2 cells correlates with the degree of enterocytic differentiation. Biochem Biophys Res Commun, 184, 1405-1410 (1992)
55. P. Gessner, S. Riedl, A. Quentmaier & W. Kemmner: Enhanced activity of CMP-neuAc:Gal beta 1-4GlcNAc:alpha 2,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients. Cancer Lett, 75, 143-149 (1993)
56. T. Petretti, W. Kemmner, B. Schulze & P. M. Schlag: Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases. Gut, 46, 359-366 (2000)
57. P. O. Skacel, A. J. Edwards, C. T. Harrison & W. M. Watkins: Enzymic control of the expression of the X determinant (CD15) in human myeloid cells during maturation: the regulatory role of 6-sialytransferase. Blood, 78, 1452-1460 (1991)
58. K. Fukushima, S. Hara-Kuge, A. Seko, Y. Ikehara & K. Yamashita: Elevation of alpha2→6 sialyltransferase and alpha1→2 fucosyltransferase activities in human choriocarcinoma. Cancer Res, 58, 4301-4306 (1998)
59. Y. Kaneko, H. Yamamoto, D. S. Kersey, K. J. Colley, J. E. Leestma & J. R. Moskal: The expression of Gal beta 1,4GlcNAc alpha 2,6 sialyltransferase and alpha 2,6-linked sialoglycoconjugates in human brain tumors. Acta Neuropathol, 91, 284-292 (1996)
60. P. H. Wang, Y. F. Li, C. M. Juang, Y. R. Lee, H. T. Chao, Y. C. Tsai & C. C. Yuan: Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix. Gynecol Oncol, 83, 121-127 (2001)
61. M. Hedlund, E. Ng, A. Varki & N. M. Varki: alpha 2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo. Cancer Res, 68, 388-394 (2008)
62. Y. Ikehara, N. Kojima, N. Kurosawa, T. Kudo, M. Kono, S. Nishihara, S. Issiki, K. Morozumi, S. Itzkowitz, T. Tsuda, S. I. Nishimura, S. Tsuji & H. Narimatsu: Cloning and expression of a human gene encoding an Nacetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancerassociated sialyl-Tn antigens. Glycobiology, 9, 1213-1224 (1999)
63. B. Samyn-Petit, M. A. Krzewinski-Recchi, W. F. Steelant, P. Delannoy & A. Harduin-Lepers: Molecular cloning and functional expression of human ST6GalNAc II. Molecular expression in various human cultured cells. Biochim Biophys Acta, 1474, 201-211 (2000)
64. T. Kjeldsen, H. Clausen, S. Hirohashi, T. Ogawa, H. Iijima & S. Hakomori: Preparation and characterization of monoclonal antibodies directed to the tumor-associated Olinked sialosyl-2-6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res, 48, 2214-2220 (1988)
65. N. T. Marcos, S. Pinho, C. Grandela, A. Cruz, B. Samyn-Petit, A. Harduin-Lepers, R. Almeida, F. Silva, V. Morais, J. Costa, J. Kihlberg, H. Clausen & C. A. Reis: Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen. Cancer Res, 64, 7050-7057 (2004)
66. C. Vazquez-Martin, E. Cuevas, E. Gil-Martin & A. Fernandez-Briera: Correlation analysis between tumorassociated antigen sialyl-Tn expression and ST6GalNAc I activity in human colon adenocarcinoma. Oncology, 67, 159-165 (2004)
67. S. Pinho, N. T. Marcos, B. Ferreira, A. S. Carvalho, M. J. Oliveira, F. Santos-Silva, A. Harduin-Lepers & C. A. Reis: Biological significance of cancer-associated sialyl-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells. Cancer Lett, 249, 157-170 (2007)
68. A. Harduin-Lepers, D. C. Stokes, W. F. Steelant, B. Samyn-Petit, M. A. Krzewinski-Recchi, V. Vallejo-Ruiz, J. P. Zanetta, C. Auge & P. Delannoy: Cloning, expression and gene organization of a human Neu5Ac alpha 2-3Gal beta 1-3GalNAc alpha 2,6-sialyltransferase: hST6GalNAcIV. Biochem J, 352 Pt 1, 37-48 (2000)
69. A. Tsuchida, M. Ogiso, Y. Nakamura, M. Kiso, K. Furukawa & K. Furukawa: Molecular cloning and expression of human ST6GalNAc III: restricted tissue distribution and substrate specificity. J Biochem, 138, 237-243 (2005)
70. A. Tsuchida, T. Okajima, K. Furukawa, T. Ando, H. Ishida, A. Yoshida, Y. Nakamura, R. Kannagi, M. Kiso & K. Furukawa: Synthesis of disialyl Lewis a (Le(a)) structure in colon cancer cell lines by a sialyltransferase, ST6GalNAc VI, responsible for the synthesis of alphaseries gangliosides. J Biol Chem, 278, 22787-22794 (2003)
71. M. Senda, A. Ito, A. Tsuchida, T. Hagiwara, T. Kaneda, Y. Nakamura, K. Kasama, M. Kiso, K. Yoshikawa, Y. Katagiri, Y. Ono, M. Ogiso, T. Urano, K. Furukawa, S. Oshima & K. Furukawa: Identification and expression of a sialyltransferase responsible for the synthesis of disialylgalactosylgloboside in normal and malignant kidney cells: downregulation of ST6GalNAc VI in renal cancers. Biochem J, 402, 459-470 (2007)
72. P. D. Bos, X. H. Zhang, C. Nadal, W. Shu, R. R. Gomis, D. X. Nguyen, A. J. Minn, M. J. van de Vijver, W. L. Gerald, J. A. Foekens & J. Massague: Genes that mediate breast cancer metastasis to the brain. Nature, 459, 1005-1009 (2009)
73. R. A. Kroes, H. He, M. R. Emmett, C. L. Nilsson, F. E. Leach, 3rd, I. J. Amster, A. G. Marshall & J. R. Moskal: Overexpression of ST6GalNAcV, a ganglioside-specific alpha2,6-sialyltransferase, inhibits glioma growth in vivo. Proc Natl Acad Sci U S A, 107, 12646-12651 (2010)
74. K. Miyazaki, K. Ohmori, M. Izawa, T. Koike, K. Kumamoto, K. Furukawa, T. Ando, M. Kiso, T. Yamaji, Y. Hashimoto, A. Suzuki, A. Yoshida, M. Takeuchi & R. Kannagi: Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers. Cancer Res, 64, 4498-4505 (2004)
75. K. Nara, Y. Watanabe, K. Maruyama, K. Kasahara, Y. Nagai & Y. Sanai: Expression cloning of a CMP-NeuAc: NeuAca2-3Galb1-4Glcb1-1'Cer a2,8-sialyltransferase (GD3 synthase) from human melanoma cells. Proc Natl Acad Sci U S A, 91, 7952-7956 (1994)
76. J. Nakayama, M. N. Fukuda, Y. Hirabayashi, A. Kanamori, K. Sasaki, T. Nishi & M. Fukuda: Expression cloning of a human GT3 synthase. GD3 and GT3 are synthesized by a single enzyme. J Biol Chem, 271, 3684-3691 (1996)
77. Y. J. Kim, K. S. Kim, S. Do, C. H. Kim, S. K. Kim & Y. C. Lee: Molecular cloning and expression of human alpha2,8-sialyltransferase (hST8Sia V). Biochem Biophys Res Commun, 235, 327-330 (1997)
78. RK Yu, E Bieberich, T Xia & G Zeng: Regulation of ganglioside biosynthesis in the nervous system. J Lipid Res., 45, 783-793 (2004)
79. M. Teintenier-Lelievre, S. Julien, S. Juliant, Y. Guerardel, M. Duonor-Cerutti, P. Delannoy & A. Harduin-Lepers: Molecular cloning and expression of a human hST8Sia VI (a2,8-sialyltransferase) responsible for the synthesis of the diSia motif on O-glycosylproteins. Biochem J, 392, 665-674 (2005)
80. A. Rohrbeck, V. S. Muller & J. Borlak: Molecular characterization of lung dysplasia induced by c-Raf-1. PLoS One, 4, e5637 (2009)
81. Y. C. Lee, Y. J. Kim, K. Y. Lee, K. S. Kim, B. U. Kim, H. N. Kim, C. H. Kim & S. I. Do: Cloning and expression of cDNA for a human Sia alpha 2,3Gal beta 1, 4GlcNA:alpha 2,8-sialyltransferase (hST8Sia III). Arch Biochem Biophys, 360, 41-46 (1998)
82. R. K. Yu, L. J. Macala, T. Taki, H. M. Weinfield & F. S. Yu: Developmental changes in ganglioside composition and synthesis in embryonic rat brain. J Neurochem, 50, 1825-1829 (1988)
83. E. Inoko, Y. Nishiura, H. Tanaka, T. Takahashi, K. Furukawa, K. Kitajima & C. Sato: Developmental stagedependent expression of an alpha2,8-trisialic acid unit on glycoproteins in mouse brain. Glycobiology, 20, 916-928 (2010)
84. K. Angata, M. Suzuki, J. McAuliffe, Y. Ding, O. Hindsgaul & M. Fukuda: Differential biosynthesis of polysialic acid on neural cell adhesion molecule (NCAM) and oligosaccharide acceptors by three distinct alpha 2,8-sialyltransferases, ST8Sia IV (PST), ST8Sia II (STX), and ST8Sia III. J Biol Chem, 275, 18594-18601 (2000)
85. C. Sato, T. Matsuda & K. Kitajima: Neuronal differentiation-dependent expression of the disialic acid epitope on CD166 and its involvement in neurite formation in Neuro2A cells. J Biol Chem, 277, 45299-45305 (2002)
86. N. Kojima, Y. Yoshida & S. Tsuji: A developmentally regulated member of the sialyltransferase family (ST8Sia II, STX) is a polysialic acid synthase. FEBS Lett, 373, 119-122 (1995)
87. J. Nakayama, M. N. Fukuda, B. Fredette, B. Ranscht & M. Fukuda: Expression cloning of a human polysialyltransferase that forms the polysialylated neural cell adhesion molecule present in embryonic brain. Proc Natl Acad Sci U S A, 92, 7031-7035 (1995)
88. E. P. Scheidegger, L. R. Sternberg, J. Roth & J. B. Lowe: A human STX cDNA confers polysialic acid expression in mammalian cells. J Biol Chem, 270, 22685-22688 (1995)
89. N. Kojima, Y. Tachida, Y. Yoshida & S. Tsuji: Characterization of mouse ST8Sia II (STX) as a neural cell adhesion molecule-specific polysialic acid synthase. Requirement of core alpha1,6-linked fucose and a polypeptide chain for polysialylation. J Biol Chem, 271, 19457-19463 (1996)
90. M. Muhlenhoff, M. Eckhardt, A. Bethe, M. Frosch & R. Gerardy-Schahn: Polysialylation of NCAM by a single enzyme. Curr Biol, 6, 1188-1191 (1996)
91. J. Nakayama, K. Angata, E. Ong, T. Katsuyama & M. Fukuda: Polysialic acid, a unique glycan that is developmentally regulated by two polysialyltransferases, PST and STX, in the central nervous system: from biosynthesis to function. Pathol Int, 48, 665-677 (1998)
92. H. Hildebrandt, M. Muhlenhoff, B. Weinhold & R. Gerardy-Schahn: Dissecting polysialic acid and NCAM functions in brain development. J Neurochem, 103 Suppl 1, 56-64 (2007)
93. Y. Matsushita, S. Yonezawa, S. Nakamori, T. Irimura & E. Sato: Carbohydrate antigens aberrantly expressed in colorectal carcinoma. Crit Rev Oncol Hematol, 25, 27-54 (1997)
94. A. Imberty, C. Gautier, J. Lescar, S. Perez, L. Wyns & R. Loris: An unusual carbohydrate binding site revealed by the structures of two Maackia amurensis lectins complexed with sialic acid-containing oligosaccharides. J Biol Chem, 275, 17541-17548 (2000)
95. S. Kurachi, Z. Song, M. Takagaki, Q. Yang, H. C. Winter, K. Kurachi & I. J. Goldstein: Sialic-acid-binding lectin from the slug Limax flavus-cloning, expression of the polypeptide, and tissue localization. Eur J Biochem, 254, 217-222 (1998)
96. F. Y. Zeng & H. J. Gabius: Sialic acid-binding proteins: characterization, biological function and application. Z Naturforsch C, 47, 641-653 (1992)
97. P. de Albuquerque Garcia Redondo, C. V. Nakamura, W. de Souza & J. A. Morgado-Diaz: Differential expression of sialic acid and N-acetylgalactosamine residues on the cell surface of intestinal epithelial cells according to normal or metastatic potential. J Histochem Cytochem, 52, 629-640 (2004)
98. Y. Shio, H. Suzuki, T. Kawaguchi, J. Ohsugi, M. Higuchi, K. Fujiu, R. Kanno, A. Ohishi & M. Gotoh: Carbohydrate status detecting by PNA is changeable through cancer prognosis from primary to metastatic nodal site: A possible prognostic factor in patient with nodepositive lung adenocarcinoma. Lung Cancer, 57, 187-192 (2007)
99. L. Johansson, P. Johansson & H. Miller-Podraza: Detection by the lectins from Maackia amurensis and Sambucus nigra of 3- and 6-linked sialic acid in gangliosides with neolacto chains separated on thin-layer chromatograms and blotted to PVDF membranes. Anal Biochem, 267, 239-241 (1999)
100. G. Harms, G. Reuter, A. P. Corfield & R. Schauer: Binding specificity of influenza C-virus to variably Oacetylated glycoconjugates and its use for histochemical detection of N-acetyl-9-O-acetylneuraminic acid in mammalian tissues. Glycoconj J, 13, 621-630 (1996)
101. R. Kannagi: Carbohydrate antigen sialyl Lewis a-its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Med J, 30, 189-209 (2007)
102. R. L. Schnaar, P. Longo, L. J. Yang & T. Tai: Distinctive ganglioside patterns revealed by antiganglioside antibody binding to differentiating CG-4 oligodendrocytes. Glycobiology, 6, 257-263 (1996)
103. C. S. Pukel, K. O. Lloyd, L. R. Travassos, W. G. Dippold, H. F. Oettgen & L. J. Old: GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody. J Exp Med, 155, 1133-1147 (1982)
104. G. Marquina, H. Waki, L. E. Fernandez, K. Kon, A. Carr, O. Valiente, R. Perez & S. Ando: Gangliosides expressed in human breast cancer. Cancer Res, 56, 5165-5171 (1996)
105. C. Costa-Nogueira, S. Villar-Portela, E. Cuevas, E. Gil-Martin & A. Fernandez-Briera: Synthesis and expression of CDw75 antigen in human colorectal cancer. BMC Cancer, 9, 431 (2009)
106. S. Gretschel, W. Haensch, P. M. Schlag & W. Kemmner: Clinical relevance of sialyltransferases ST6GAL-I and ST3GAL-III in gastric cancer. Oncology, 65, 139-145 (2003)
107. A. Harduin-Lepers, D. Petit, R. Mollicone, P. Delannoy, J. M. Petit & R. Oriol: Evolutionary history of the alpha2,8-sialyltransferase (ST8Sia) gene family: tandem duplications in early deuterostomes explain most of the diversity found in the vertebrate ST8Sia genes. BMC Evol Biol, 8, 258 (2008)
108. M. Hebbar, M. A. Krzewinski-Recchi, L. Hornez, A. Verdiere, A. Harduin-Lepers, J. Bonneterre, P. Delannoy & J. P. Peyrat: Prognostic value of tumoral sialyltransferase expression and circulating E-selectin concentrations in node-negative breast cancer patients. Int J Biol Markers, 18, 116-122 (2003)
109. I. Y. Cheung, A. Vickers & N. K. Cheung: Sialyltransferase STX (ST8SiaII): a novel molecular marker of metastatic neuroblastoma. Int J Cancer, 119, 152-156 (2006)
110. N. Patani, W. Jiang & K. Mokbel: Prognostic utility of glycosyltransferase expression in breast cancer. Cancer Genomics Proteomics, 5, 333-340 (2008)
111. F. Fialka, R. M. Gruber, R. Hitt, L. Opitz, E. Brunner, H. Schliephake & F. J. Kramer: CPA6, FMO2, LGI1, SIAT1 and TNC are differentially expressed in early- and late-stage oral squamous cell carcinoma-a pilot study. Oral Oncol, 44, 941-948 (2008)
112. E. Ruckhaberle, T. Karn, A. Rody, L. Hanker, R. Gatje, D. Metzler, U. Holtrich & M. Kaufmann: Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer. J Cancer Res Clin Oncol, 135, 1005-1013 (2009)
113. W. Kemmner, C. Roefzaad, W. Haensch & P. M. Schlag: Glycosyltransferase expression in human colonic tissue examined by oligonucleotide arrays. Biochim Biophys Acta, 1621, 272-279 (2003)
114. R. A. Kroes, G. Dawson & J. R. Moskal: Focused microarray analysis of glyco-gene expression in human glioblastomas. J Neurochem, 103 Suppl 1, 14-24 (2007)
115. C. Y. Wu, C. C. Hsu, S. T. Chen & Y. C. Tsai: Soyasaponin I, a potent and specific sialyltransferase inhibitor. Biochem Biophys Res Commun, 284, 466-469 (2001)
116. D. Skropeta, R. Schworer, T. Haag & R. R. Schmidt: Asymmetric synthesis and affinity of potent sialyltransferase inhibitors based on transition-state analogues. Glycoconj J, 21, 205-219 (2004)
117. L. J. Whalen, K. A. McEvoy & R. L. Halcomb: Synthesis and evaluation of phosphoramidate amino acid-based inhibitors of sialyltransferases. Bioorg Med Chem Lett, 13, 301-304 (2003)
118. X. Wang, L. H. Zhang & X. S. Ye: Recent development in the design of sialyltransferase inhibitors. Med Res Rev, 23, 32-47 (2003)
119. K. Y. Lee, H. G. Kim, M. R. Hwang, J. I. Chae, J. M. Yang, Y. C. Lee, Y. K. Choo, Y. I. Lee, S. S. Lee & S. I. Do: The Hexapeptide inhibitor of Galbeta 1,3GalNAc-specific alpha 2,3-sialyltransferase as a generic inhibitor of sialyltransferases. J Biol Chem, 277, 49341-49351 (2002)
120. A. K. Sarkar, T. A. Fritz, W. H. Taylor & J. D. Esko: Disaccharide uptake and priming in animal cells: inhibition of sialyl Lewis X by acetylated Gal beta 1→4GlcNAc beta-O-naphthalenemethanol. Proc Natl Acad Sci U S A, 92, 3323-3327 (1995)
121. I. Kijima-Suda, Y. Miyamoto, S. Toyoshima, M. Itoh & T. Osawa: Inhibition of experimental pulmonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid:nucleoside conjugate having sialyltransferase inhibiting activity. Cancer Res, 46, 858-862 (1986)
122. I. Kijima-Suda, T. Miyazawa, M. Itoh, S. Toyoshima & T. Osawa: Possible mechanism of inhibition of experimental pulmonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid: nucleoside conjugate. Cancer Res, 48, 3728-3732 (1988)
123. K. H. Chang, L. Lee, J. Chen & W. S. Li: Lithocholic acid analogues, new and potent alpha-2,3-sialyltransferase inhibitors. Chem Commun (Camb)629-631 (2006)
124. C. H. Chiang, C. H. Wang, H. C. Chang, S. V. More, W. S. Li & W. C. Hung: A novel sialyltransferase inhibitor AL10 suppresses invasion and metastasis of lung cancer cells by inhibiting integrin-mediated signaling. J Cell Physiol, 223, 492-499 (2010)
125. J. Y. Chen, Y. A. Tang, S. M. Huang, H. F. Juan, L. W. Wu, Y. C. Sun, S. C. Wang, K. W. Wu, G. Balraj, T. T. Chang, W. S. Li, H. C. Cheng & Y. C. Wang: A Novel Sialyltransferase Inhibitor Suppresses FAK/Paxillin Signaling and Cancer Angiogenesis and Metastasis Pathways. Cancer Res, 71, 473-483 (2011)
126. P. Delannoy, I. Kim, N. Emery, C. De Bolos, A. Verbert, P. Degand & G. Huet: Benzyl-N-acetyl-alpha-Dgalactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation. Glycoconj J, 13, 717-726 (1996)
127. T. Nakano, T. Matsui & T. Ota: Benzyl-alpha-GalNAc inhibits sialylation of O-glycosidic sugar chains on CD44 and enhances experimental metastatic capacity in B16BL6 melanoma cells. Anticancer Res, 16, 3577-3584 (1996)
128. G. Zeng, L. Gao, S. Birkle & R. K. Yu: Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production. Cancer Res, 60, 6670-6676 (2000)
129. G. Zeng, D. D. Li, L. Gao, S. Birkle, E. Bieberich, A. Tokuda & R. K. Yu: Alteration of ganglioside composition by stable transfection with antisense vectors against GD3-synthase gene expression. Biochemistry, 38, 8762-8769 (1999)
130. S. Birkle, L. Gao, G. Zeng & R. K. Yu: Downregulation of GD3 ganglioside and its O-acetylated derivative by stable transfection with antisense vector against GD3-synthase gene expression in hamster melanoma cells: effects on cellular growth, melanogenesis, and dendricity. J Neurochem, 74, 547-554 (2000)
131. K. Ko, K. Furukawa, T. Takahashi, T. Urano, Y. Sanai, M. Nagino, Y. Nimura & K. Furukawa: Fundamental study of small interfering RNAs for ganglioside GD3 synthase gene as a therapeutic target of lung cancers. Oncogene, 25, 6924-6935 (2006)
132. Y. Gu, J. Zhang, W. Mi, J. Yang, F. Han, X. Lu & W. Yu: Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells. Breast Cancer Res, 10, R1 (2008)
133. S. Lin, W. Kemmner, S. Grigull & P. M. Schlag: Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells. Exp Cell Res, 276, 101-110 (2002)
134. Y. Zhu, U. Srivatana, A. Ullah, H. Gagneja, C. S. Berenson & P. Lance: Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro. Biochim Biophys Acta, 1536, 148-160 (2001)
135. A. V. Nairn, W. S. York, K. Harris, E. M. Hall, J. M. Pierce & K. W. Moremen: Regulation of glycan structures in animal tissues: transcript profiling of glycan-related genes. J Biol Chem, 283, 17298-17313 (2008)
136. A Taniguchi: Promoter structure and transcriptional regulation of human β-galactoside α2,3-sialyltransferase genes. Current Drug Targets, 9, 310-316 (2008)
137. I. Kalcheva, R. W. Elliott, M. Dalziel & J. T. Lau: The gene encoding beta-galactoside alpha2,6-sialyltransferase maps to mouse chromosome 16. Mamm Genome, 8, 619-620 (1997)
138. D. Mercier, A. Wierinckx, A. Oulmouden, P. F. Gallet, M. M. Palcic, A. Harduin-Lepers, P. Delannoy, J. M. Petit, H. Leveziel & R. Julien: Molecular cloning, expression and exon/intron organization of the bovine beta-galactoside alpha2,6-sialyltransferase gene. Glycobiology, 9, 851-863 (1999)
139. X. Wang, A. Vertino, R. L. Eddy, M. G. Byers, S. N. Jani-Sait, T. B. Shows & J. T. Lau: Chromosome mapping and organization of the human beta-galactoside alpha 2,6-sialyltransferase gene. Differential and cell-type specific usage of upstream exon sequences in B-lymphoblastoid cells. J Biol Chem, 268, 4355-4361 (1993)
140. D. X. Wen, E. C. Svensson & J. C. Paulson: Tissuespecific alternative splicing of the beta-galactoside alpha 2,6-sialyltransferase gene. J Biol Chem, 267, 2512-2518 (1992)
141. F. Dall'Olio, M. Chiricolo, C. Ceccarelli, F. Minni, D. Marrano & D. Santini: Beta-galactoside alpha2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity with Sambucus nigra agglutinin. Int J Cancer, 88, 58-65 (2000)
142. L. Xu, Y. Kurusu, K. Takizawa, J. Tanaka, K. Matsumoto & A. Taniguchi: Transcriptional regulation of human beta-galactoside alpha2,6-sialyltransferase (hST6Gal I) gene in colon adenocarcinoma cell line. Biochem Biophys Res Commun, 307, 1070-1074 (2003)
143. R. Eskinazi, B. Thony, M. Svoboda, P. Robberecht, D. Dassesse, C. W. Heizmann, J. L. Van Laethem & A. Resibois: Overexpression of pterin-4a-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 in human colon cancer. Am J Pathol, 155, 1105-1113 (1999)
144. P. H. Wang, W. L. Lee, Y. R. Lee, C. M. Juang, Y. J. Chen, H. T. Chao, Y. C. Tsai & C. C. Yuan: Enhanced expression of alpha 2,6-sialyltransferase ST6Gal I in cervical squamous cell carcinoma. Gynecol Oncol, 89, 395-401 (2003)
145. H. M. Dae, H. Y. Kwon, N. Y. Kang, N. R. Song, K. S. Kim, C. H. Kim, J. H. Lee & Y. C. Lee: Isolation and functional analysis of the human glioblastoma-specific promoter region of the human GD3 synthase (hST8Sia I) gene. Acta Biochim Biophys Sin (Shanghai), 41, 237-245 (2009)
146. K. Furukawa, M. Horie, K. Okutomi, S. Sugano & K. Furukawa: Isolation and functional analysis of the melanoma specific promoter region of human GD3 synthase gene. Biochim Biophys Acta, 1627, 71-78 (2003)
147. N. Y. Kang, C. H. Kim, K. S. Kim, J. H. Ko, J. H. Lee, Y. K. Jeong & Y. C. Lee: Expression of the human CMPNeuAc: GM3 alpha2,8-sialyltransferase (GD3 synthase) gene through the NF-kappaB activation in human melanoma SKMEL-2 cells. Biochim Biophys Acta, 1769, 622-630 (2007)
148. J. M. Yang, J. C. Byrd, B. B. Siddiki, Y. S. Chung, M. Okuno, M. Sowa, Y. S. Kim, K. L. Matta & I. Brockhausen: Alterations of O-glycan biosynthesis in human colon cancer tissues. Glycobiology, 4, 873-884 (1994)
149. F. G. Hanisch, T. R. Stadie, F. Deutzmann & J. Peter-Katalinic: MUC1 glycoforms in breast cancer-cell line T47D as a model for carcinoma-associated alterations of 0-glycosylation. Eur J Biochem, 236, 318-327 (1996)
150. K. O. Lloyd, J. Burchell, V. Kudryashov, B. W. Yin & J. Taylor-Papadimitriou: Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J Biol Chem, 271, 33325-33334 (1996)
151. J. Taylor-Papadimitriou, J. Burchell, D. W. Miles & M. Dalziel: MUC1 and cancer. Biochim Biophys Acta, 1455, 301-313 (1999)
152. S. Muller & F. G. Hanisch: Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. High density and prevalent core 2-based glycosylation. J Biol Chem, 277, 26103-26112 (2002)
153. K. Sebova & I. Fridrichova: Epigenetic tools in potential anticancer therapy. Anticancer Drugs, 21, 565-577 (2010)
154. R. Kannagi, J. Yin, K. Miyazaki & M. Izawa: Current relevance of incomplete synthesis and neo-synthesis for cancer-associated alteration of carbohydrate determinants-Hakomori's concepts revisited. Biochim Biophys Acta, 1780, 525-531 (2008)
155. Y. I. Kawamura, M. Toyota, R. Kawashima, T. Hagiwara, H. Suzuki, K. Imai, Y. Shinomura, T. Tokino, R. Kannagi & T. Dohi: DNA hypermethylation contributes to incomplete synthesis of carbohydrate determinants in gastrointestinal cancer. Gastroenterology, 135, 142-151 e143 (2008)
156. V. B. Chachadi, H. Cheng, D. Klinkebiel, J. K. Christman & P. W. Cheng: 5-Aza-2′-deoxycytidine increases sialyl Lewis X on MUC1 by stimulating betagalactoside: alpha2,3-sialyltransferase 6 gene. Int J Biochem Cell Biol (2011)
157. C. D. Margetts, M. Morris, D. Astuti, D. C. Gentle, A. Cascon, F. E. McRonald, D. Catchpoole, M. Robledo, H. P. Neumann, F. Latif & E. R. Maher: Evaluation of a functional epigenetic approach to identify promoter region methylation in phaeochromocytoma and neuroblastoma. Endocr Relat Cancer, 15, 777-786 (2008)
158. A. Harduin-Lepers, M. A. Krzewinski-Recchi, M. Hebbar, B. Samyn-Petit, V. Vallejo-Ruiz, S. Julien, J.P. Peyrat & P. Delannoy: Sialyltransferases and breast cancer. Recent Res. Devel. Cancer, 3, 111-126 (2001)
159. J. Ma, M. Simonovic, R. Qian & K. J. Colley: Sialyltransferase isoforms are phosphorylated in the cismedial Golgi on serine and threonine residues in their luminal sequences. J Biol Chem, 274, 8046-8052 (1999)
160. K. C. Breen & N. Georgopoulou: The role of protein phosphorylation in alpha2,6(N)-sialyltransferase activity. Biochem Biophys Res Commun, 309, 32-35 (2003)
161. E. Bieberich, B. Freischutz, S. S. Liour & R. K. Yu: Regulation of ganglioside metabolism by phosphorylation and dephosphorylation. J Neurochem, 71, 972-979 (1998)
162. D. Skropeta: The effect of individual N-glycans on enzyme activity. Bioorg Med Chem, 17, 2645-2653 (2009)
163. P. Broquet, P. George, J. Geoffroy, P. Reboul & P. Louisot: Study of O-glycan sialylation in C6 cultured glioma cells: evidence for post-translational regulation of a beta-galactoside alpha 2,3 sialyltransferase activity by Nglycosylation. Biochem Biophys Res Commun, 178, 1437-1443 (1991)
164. C. Chen & K. J. Colley: Minimal structural and glycosylation requirements for ST6Gal I activity and trafficking. Glycobiology, 10, 531-583 (2000)
165. E. Bieberich, T. Tencomnao, D. Kapitonov & R. K. Yu: Effect of N-glycosylation on turnover and subcellular distribution of N- acetylgalactosaminyltransferase I and sialyltransferase II in neuroblastoma cells. J Neurochem, 74, 2359-2364 (2000)
166. C. Jeanneau, V. Chazalet, C. Auge, D. M. Soumpasis, A. Harduin-Lepers, P. Delannoy, A. Imberty & C. Breton: Structure-function analysis of the human sialyltransferase ST3Gal I: role of N-glycosylation and a novel conserved sialylmotif. J Biol Chem, 279, 13461-13468 (2004)
167. D. G. Fast, J. C. Jamieson & G. McCaffrey: The role of the carbohydrate chains of Gal beta-1,4-GlcNAc alpha 2,6-sialyltransferase for enzyme activity. Biochim Biophys Acta, 1202, 325-330 (1993)
168. J. A. Martina, J. L. Daniotti & H. J. Maccioni: GM1 synthase depends on N-glycosylation for enzyme activity and trafficking to the Golgi complex. Neurochem Res, 25, 725-731 (2000)
169. M. Muhlenhoff, A. Manegold, M. Windfuhr, B. Gotza & R. Gerardy-Schahn: The impact of N-glycosylation on the functions of polysialyltransferases. J Biol Chem, 276, 34066-34073 (2001)
170. S. Uemura, T. Kurose, T. Suzuki, S. Yoshida, M. Ito, M. Saito, M. Horiuchi, F. Inagaki, Y. Igarashi & J. Inokuchi: Substitution of the N-glycan function in glycosyltransferases by specific amino acids: ST3Gal-V as a model enzyme. Glycobiology, 16, 258-270 (2006)
171. L. E. Gerweck & K. Seetharaman: Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res, 56, 1194-1198 (1996)
172. G. R. Martin & R. K. Jain: Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy. Cancer Res, 54, 5670-5674 (1994)
173. S. Kellokumpu, R. Sormunen & I. Kellokumpu: Abnormal glycosylation and altered Golgi structure in colorectal cancer: dependence on intra-Golgi pH. FEBS Lett, 516, 217-224 (2002)
174. A. Rivinoja, N. Kokkonen, I. Kellokumpu & S. Kellokumpu: Elevated Golgi pH in breast and colorectal cancer cells correlates with the expression of oncofetal carbohydrate T-antigen. J Cell Physiol, 208, 167-174 (2006)
175. A. Rivinoja, A. Hassinen, N. Kokkonen, A. Kauppila & S. Kellokumpu: Elevated Golgi pH impairs terminal Nglycosylation by inducing mislocalization of Golgi glycosyltransferases. J Cell Physiol, 220, 144-154 (2009)
176. C. Chen, J. Ma, A. Lazic, M. Backovic & K. J. Colley: Formation of insoluble oligomers correlates with ST6Gal I stable localization in the golgi. J Biol Chem, 275, 13819-13826 (2000)
177. A. El-Battari, M. Prorok, K. Angata, S. Mathieu, M. Zerfaoui, E. Ong, M. Suzuki, D. Lombardo & M. Fukuda: Different glycosyltransferases are differentially processed for secretion, dimerization, and autoglycosylation. Glycobiology, 13, 941-953 (2003)
178. F. H. Fenteany & K. J. Colley: Multiple signals are required for alpha2,6-sialyltransferase (ST6Gal I) oligomerization and Golgi localization. J Biol Chem, 280, 5423-5429 (2005)
179. J. Ma & K. J. Colley: A disulfide-bonded dimer of the Golgi beta-galactoside alpha2,6-sialyltransferase is catalytically inactive yet still retains the ability to bind galactose. J Biol Chem, 271, 7758-7766 (1996)
180. S. Tsuji, A. K. Datta & J. C. Paulson: Systematic nomenclature for sialyltransferases. Glycobiology, 6, v-vii (1996)
181. L. Svennerholm: The Gangliosides. J Lipid Res, 5, 145-155 (1964)
182. N. Matsuura, T. Narita, N. Hiraiwa, M. Hiraiwa, H. Murai, T. Iwase, H. Funahashi, T. Imai, H. Takagi & R. Kannagi: Gene expression of fucosyl- and sialyltransferases which synthesize sialyl Lewisx, the carbohydrate ligands for E-selectin, in human breast cancer. Int J Oncol, 12, 1157-1164 (1998)
183. J. Muthing, I. Meisen, B. Kniep, J. Haier, N. Senninger, U. Neumann, M. Langer, K. Witthohn, J. Milosevic & J. Peter-Katalinic: Tumor-associated CD75s gangliosides and CD75s-bearing glycoproteins with Neu5Acalpha2-6Galbeta1- 4GlcNAc-residues are receptors for the anticancer drug rViscumin. Faseb J, 19, 103-105 (2005)
184. A. Cazet, S. Groux-Degroote, B. Teylaert, K. M. Kwon, S. Lehoux, C. Slomianny, C. H. Kim, X. Le Bourhis & P. Delannoy: GD3 synthase overexpression enhances proliferation and migration of MDA-MB-231 breast cancer cells. Biol Chem, 390, 601-609 (2009)
185. B. D. Livingston, J. L. Jacobs, M. C. Glick & F. A. Troy: Extended polysialic acid chains (n greater than 55) in glycoproteins from human neuroblastoma cells. J Biol Chem, 263, 9443-9448 (1988)
186. M. H. Shah, S. D. Telang, P. M. Shah & P. S. Patel: Tissue and serum alpha 2-3- and alpha 2-6-linkage specific sialylation changes in oral carcinogenesis. Glycoconj J, 25, 279-290 (2008)
187. F. Dall'Olio, M. Chiricolo, A. D'Errico, E. Gruppioni, A. Altimari, M. Fiorentino & W. F. Grigioni: Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis. Glycobiology, 14, 39-49 (2004)
188. F. L. Wang, S. X. Cui, L. P. Sun, X. J. Qu, Y. Y. Xie, L. Zhou, Y. L. Mu, W. Tang & Y. S. Wang: High expression of alpha 2, 3-linked sialic acid residues is associated with the metastatic potential of human gastric cancer. Cancer Detect Prev, 32, 437-443 (2009)
189. M. Chovanec, J. Plzak, J. Betka, J. Brabec, R. Kodet & K. Smetana, Jr.: Comparative analysis of alpha2,3/2,6-linked N-acetylneuraminic acid and cytokeratin expression in head and neck squamous cell carcinoma. Oncol Rep, 12, 297-301 (2004)